ARCHIVES

April issue of Business & Regulatory Report included (8 additional pages).

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

June 11, 2014

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

March 18, 2011

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002